Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Cesca Therapeutics Inc.
(KOOL:NASDAQ)
Cesca Therapeutics' Chief Executive Officer, Chris Xu, To Be The Keynote Speaker At The Cell Therapy World Asia 2018 Conference On September 20, 2018 (9/13/2018)
view
ProMIS Neurosciences Inc.
(PMN:TSX; PMN:NCM)
ProMIS Neurosciences Appoints James Kupiec, MD as Chief Medical Officer (9/13/2018)
view
Celgene Corp.
(CELG:NASDAQ)
Zacks.com featured highlights include: Nucor, PCM, Celgene and Rayonier (9/13/2018)
view
Celgene Corp.
(CELG:NASDAQ)
Celgene (CELG) Stock Sinks As Market Gains: What You Should Know (9/12/2018)
view
Celgene Corp.
(CELG:NASDAQ)
IPOs and Foreign Investment Propel Biotech: 4 Top Picks (9/13/2018)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn® (9/13/2018)
view
Caladrius Biosciences Inc.
(CLBS:NASDAQ)
Is Caladrius Biosciences (CLBS) Stock Outpacing Its Medical Peers This Year? (9/12/2018)
view
Celgene Corp.
(CELG:NASDAQ)
Endocyte Announces FDA's Acceptance of Trial Endpoint Change (9/11/2018)
view
Celgene Corp.
(CELG:NASDAQ)
Immuno Oncology & Targeted Therapy Companies Set to Breakout (9/12/2018)
view
Celgene Corp.
(CELG:NASDAQ)
Boost Your Portfolio With These 4 High Earnings Yield Stocks (9/12/2018)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm to Present at FDA and Scientific Workshops Highlighting Innovation in ALS Trial Designs and Continued Progress with NurOwn® Cellular Therapy Platform (9/12/2018)
view
Caladrius Biosciences Inc.
(CLBS:NASDAQ)
Danforth Advisors Names Robert Dickey IV Managing Director, Mid Atlantic Region (9/11/2018)
view
Nu-Med Plus Inc.
(NUMD:OTCMKTS)
Nu-Med Plus, Inc. Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study (9/11/2018)
view